Author: Staff Corvelva
These latest analyses were made possible thanks to the active contribution of the French associations Association Liberté Informations Santé (ALIS), Ligue nationale pour la liberté des vaccinations (LNPLV) and the Australian Association Australian Vaccination-risks Network (AVN), that we thank.
New generation sequencing have become the preferred tool for in-depth analysis in the field of biology and medical science, especially high precision ones. Thanks to these tools, we can approach in a more modern and comprehensive way a number of applications such as de novo sequencing, metagenomic and epigenomic studies, transcriptome sequencing and genome re-sequencing.
This last one (re-sequencing) is largely used in human field, both for research and diagnostic purposes and consists of NGS - Next Generation Sequencing of an entire single genome, to map the Single Nucleotide mutations (SNP), insertions and deletions of more or less long sequences that have occurred in certain locations of the genome, and variations in the number of copies of genomic portions/genes (CNV, Copy Number Variants).
This procedure helps to understand the development mechanism of some pathologies, in order to identify the directions for a future clinical treatment as in the case of cancer for example. Indeed, by this method the genetic heritage of a cancer patient can be fully decoded in both normal and cancerous tissue, thus allowing us to comprehend what exactly has changed within the genome, and, if possible, how to intervene with targeted measures.
The re-sequencing procedure requires that the DNA of an individual is mechanically broken into small dimension fragments (400-500 base pairs) and artificial DNA parts named adapters are tied to these fragments; adapters make it possible to tie the human DNA fragments to a glass surface on which the bases reading (A, C, G, T) is performed. The DNA base pairs reading takes place by means of chemical reactions, namely the incorporation of nucleotides that have been marked by fluorescent molecules. The million sequences (reads) thus obtained are then mapped on the human reference genome by specific software and all the variants are identified comparing the analyzed genome with the reference genome.
This same procedure has been performed on the human genome in Priorix® Tetra lot n. A71CB256A, genome which belongs to cell line MRC-5 (of fetal origin); the work has been carried out by a company in the USA, that routinely deals with human genome re-sequencing analysis. *
*the name of the laboratory that has performed the analysis will be included in the next formal complaint we will file at the Public Prosecutor of Rome and as well at the Italian and European regulatory bodies. The associations who are filing the analysis funded by Corvelva will be promptly kept up to date with these shocking results too. We are no denying that we feel, especially as parents, distressed by these results we are reporting - as if what we have found out so far was not enough to worry about.
During our September 18 debate, Spectrum TV host Renee Eng asked Kaiser’s, Dr. Robert Riewerts, how many vaccine injuries he had seen during his 30 years as a Pediatrician. His answer: “None, not a single one.”
Slide 1. A 2010 HHS pilot study by the AHCR.
Slide 1 shows a 2010 U.S. Health and Human Services (HHS) pilot study by the Federal Agency for Health Care Research (AHCR) to test the efficiency of a state-of-the-art machine counting (AI) system on data records from the Harvard Pilgrim HMO. Those government researchers found that 2.6% of vaccination resulted in injuries—a ratio one for every 39 vaccines administered. The same study found that typical clinicians see 1.3 vaccine injuries per month.
Author: The Corvelva Team
The Italian vaccine research and advocacy organization Corvelva recently released new data regarding the use of aborted fetal cell lines in vaccines. The research reports the results produced from the MRC 5 cell line analysis, particularly the one contained in GlaxoSmithKline’s tetravalent measles-mumps-rubella-chickenpox (MMRV) vaccine.
None of the Part 5 articles I summarize below and in the accompanying graphs are true vax/unvaxxed studies. Instead, the researchers looked at the results on overall health after the addition of a single vaccine dose or vaccine to an already heavily vaccinated population. The results are still striking. They all show a statistically significant increase in grave chronic diseases associated with even incremental uptake in vaccines. These data, even without the shocking results in my earlier Part 1 through 4 editions, ought to set off an emergency mobilization within any honest regulatory agency.
Titles and Summaries from Part 5 Vaxxed/Unvaxxed Slides:
Addition of the Hepatitis B Vaccine in 1988 Increased the Rate of Type 1 Diabetes 1.62X in Children in New Zealand. The incidence of type I diabetes in person 0-19 years old living in Christchurch rose from 11.2 cases per 100,000 children annually in the years before the immunization program, 1982-1987, to 18.1 cases per 100,000 children annually ( P = .0008) in the years following the immunization, 1989-1991.
DTP Vaccination Increases Mortality by 2.45X in Girls Previously Receiving the BCG (Tuberculosis) Vaccine. In seven studies of the BCG-vaccinated children, DTP vaccination was associated with a 2.54 (95% CI 1.68-3.86) increase in mortality in girls (with no increase in boys [ratio 0.96, 0.55-1.68]). The ways in which the female and male immune systems may respond differently to vaccinations in infants are only beginning to be studied.
Higher Number of Vaccine Doses Prior to One Year of Age Increases Infant Mortality by 1.83X. Using the Tukey-Kramer test, statistically significant differences in mean IMRs (infant mortality rates) were found between nations giving 12-14 vaccine doses and those giving 21-23 and 24-26 doses.
One Dose of the DTP Vaccine Increases Infant Mortality by 1.84X. One dose of diphtheria, tetanus, and pertussis vaccine was associated with a mortality ratio of 1.84 (1.10 to 3.10) and two to three doses with a ratio of 1.38 (0.73 to 2.61) compared with children who had received no dose of these vaccines.
Early DTP Vaccination in Girls Increased Infant Mortality by 5.68X. Surprisingly, even though the children with the best nutritional status were vaccinated early, early DTP vaccination was associated with increased mortality.
Receipt of Both the BCG and DTP Vaccines Increased Infant Mortality in Girls by 2.4X.Among girls, those who received bot BCG and DTP experienced higher mortality than those who received only one of the two vaccines (hazards ratio 2.4; 95% confidence interval 1.2-5.0)
Receipt of the Second and Third Dose of the DTP Vaccine Increases Infant Mortality by 4.36X. The MR (Mortality Rate) was 1.81 (95% CI: 0.95, 3.45) for the first dose of DTP and 4.36 (95% CI: 1.28, 14.9) for the second and third dose.
(See full-sized Part 5 slides or see the complete Vaxxed-Unvaxxed presentation, Parts 1-5.)
Read More: Here
Facebook's vicious cycle: Regularly using social media causes people to get stressed which then fuels addiction to the sites
Author: Ian Randall
EEE fears sweep US: Officials in 3 states warn residents to stay inside at dawn and dusk and to NOT touch dying birds
Author: Natalie Rahhal
Mr. Paumgarten, it’s long past time to address the misinformation in articles like yours, The Message of Measles, which paints such an intensely biased, extremist picture of those who delay or even refuse vaccines, that by my definition, it does not qualify as journalism.
In the first place, please stop calling us “anti-vaxxers.” WE VACCINATED OUR CHILDREN. Our sons and daughters had medically-documented, serious adverse reactions to vaccines. Not redness, swelling, or a little fever, but autoimmune reactions, neurological reactions like seizure, encephalopathy, or loss of consciousness, and a host of others with long-term sequelae. Yet our children’s injuries are dismissed and ignored, while we are inexplicably —and unethically— told we must continue to vaccinate to protect others.
Why wouldn’t we protest?
When the Centers for Disease Control and Prevention (CDC) released its biannual overview of autism prevalence in early 2018, it reported that one in fifty-nine 8-year-olds (born in 2006) had an autism spectrum disorder (ASD). This represented a 15% increase from the rate of one in sixty-eight described in the CDC’s 2016 and 2014 reports (for 8-year-olds born in 2004 and 2002, respectively). A federal snapshot of 3 through 17 year-olds in 2016 reported diagnosed autism in one in thirty-six children--23% more than in 2014.
Despite the two-year jump in ASD prevalence, the CDC cast a positive spin on its 2018 findings. Recognizing that white ASD prevalence had been higher, in the past, than prevalence among other race/ethnicity groups, the agency hypothesized that “white ASD prevalence had largely stabilized” and praised the 15% increased prevalence as a reflection of “the catch-up of Hispanics and blacks who had been historically underascertained.” The media readily acquiesced to this worn-out narrative, implying that latent autism cases had simply been waiting to be discovered through more effective outreach and better screening. According to PBS, “[I]f it’s the case that the rate grew only because of better diagnosis, that would mean that autism spectrum disorder isn’t becoming more common among American children. Doctors are just better at spotting it.”
Dissatisfied with the “better diagnosis” explanation, University of Colorado researcher Cynthia Nevison wrote of a 1000-fold increase in autism prevalence since the 1930s and a 25-fold increase since the 1970s in a December 2018 publication in the Journal of Autism and Developmental Disorders. Now, Nevison and Rutgers researcher Walter Zahorodny—who regularly contributes New Jersey data to the biannual CDC reports—have published a new study critiquing the “catch-up” hypothesis. Their analysis further undermines officials’ complacent narrative by highlighting upward ASD trends among black and Hispanic children above and beyond mere “catch-up”—as well as pointing to worsening racial/ethnic disparities.
In the United States and Canada, exposure to fluoride is widespread and comes primarily through ingestion of fluoridated water supplied by community water systems. Although some U.S. residents consume drinking water that is fluoride-free, the majority of Americans served by community utilities—an estimated 74%—receive water to which industrial fluoride compounds have been added. The utilities do so in accordance with Centers for Disease Control and Prevention (CDC) and U.S. Public Health Service (USPHS) recommendations, which promote water fluoridation for the purpose of altering the consumer’s oral health.
The CDC acknowledges no dangers of water fluoridation other than mentioning the risk of dental fluorosis. However, as the first—and most visible—sign of fluoride toxicity, dental fluorosis should trouble the nation’s leading public health agency, particularly given that mild to severe fluorosis affected fully two-thirds of 12- to 15-year-olds as of 2012.
Even more worryingly, dozens of studies outside the U.S. have linked fluoride exposure to reduced IQ. Each time one of the studies appears, American media outlets—which represent “a powerful tool for directing [or not directing] attention to specific issues”—have remained mostly silent. For example, a rigorous Mexico-based study published in September 2017 went without mention by virtually all the major U.S. media, despite being funded by the U.S. government. For some reason, the latest study on fluoride’s IQ effects (published on August 19) has received more attention, perhaps because it appeared in one of the nation’s top pediatric journals, JAMA Pediatrics. Once again funded in part by the U.S. government, the Canada-based study indicates that moms’ exposure to fluoride during pregnancy can result in lower IQ scores in their children. These conclusions may discomfit fluoride’s most ardent proponents, but, as the study’s senior author states, “It’s important that decisions about safety…be based on evidence.”